Plain-English translation of NCT04230421 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bipolar Disorder research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether using a smartphone app called Monsenso—which tracks your daily mood and connects you with your care team—can improve how well bipolar disorder treatment works. The study will compare three groups: people using the app with regular feedback from doctors, people using the app without that feedback, and people receiving standard care with basic mood tracking only. The goal is to see whether this digital tool can help you stay more stable and improve your quality of life.
Bipolar disorder is hard to manage because it changes constantly—from manic to depressed to stable states—and patients often struggle with quality of life and staying connected to treatment. New smartphone tools might help doctors monitor patients better and provide faster support, but scientists haven't fully tested whether these tools actually work in real clinical practice.
You'll be randomly assigned to one of three groups: using the smartphone app with feedback from your doctor, using the app without feedback, or receiving standard care with basic mood tracking. Each day, you'll use the app to record your mood and symptoms. If you're in a feedback group, your care team will review your data and may reach out if they notice patterns. The study involves patients from five mental health centers in Copenhagen and will help doctors understand whether this smartphone tool improves treatment outcomes over time.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Denmark
Sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Collaborators
Maria Faurholt-Jepsen, MD, DMSc, The Mental Health Services in the Capital Region of Denmark
Enrollment target
~200 participants
Started
March 2021
Primary completion
July 2025
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lars Vedel Kessing, Prof., MD, DMSc
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital